Related Experiment Video
Updated: Jul 18, 2026

12:10
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
Karolinska prostatectomy: a robot-assisted laparoscopic radical prostatectomy technique
Andreas E Nilsson1, Stefan Carlsson, Brett A Laven
1Department of Urology, Division of Surgery, Karolinska University Hospital, Stockholm, Sweden. andreas.nilsson@karolinska.se
Scandinavian Journal of Urology and Nephrology
|November 30, 2006
Summary
This study details an improved robot-assisted laparoscopic radical prostatectomy technique. The refined approach enhances surgical efficiency and reduces costs while achieving excellent oncological and functional outcomes for prostate cancer patients.
Area of Science:
- Urology
- Surgical Oncology
- Minimally Invasive Surgery
Background:
- Minimally invasive surgery, including robot-assisted laparoscopic prostatectomy, is increasingly used for prostate cancer management.
- Several laparoscopic techniques exist, but optimal outcomes remain unclear.
Purpose of the Study:
- To present a refined technique for robot-assisted laparoscopic radical prostatectomy.
- To highlight modifications aimed at improving efficiency and reducing costs.
Main Methods:
- The technique evolved over 400+ procedures since 2002.
- Modifications include extended posterior dissection, bladder neck-sparing dissection, and specific nerve-sparing and apical anatomy preservation techniques.
- Fewer robotic instruments are utilized to decrease costs.
Main Results:
- The described technique facilitates a more fluent dissection compared to other robotic methods.
- Minimizing instrument and camera changes reduces operating time and costs.
- The technique has yielded excellent functional and oncological results in the authors' experience.
Conclusions:
- This refined robot-assisted laparoscopic radical prostatectomy technique offers advantages in surgical efficiency and cost-effectiveness.
- The approach has demonstrated success in achieving favorable oncological and functional outcomes for prostate cancer patients.
